Optimizing Therapy for Endometrial Cancer: Recent Data Highlights - Episode 11

Expanding Horizons in Endometrial Cancer Treatment: Beyond Chemotherapy

,

Delve into the exciting developments in endometrial cancer treatment, including HER2 antibody drug conjugates, checkpoint inhibitors, and the promising impact of these therapies in the quest to reduce chemotherapy use.

EP. 1: Changing Landscape of Endometrial Cancer: Incidence and Classification
EP. 2: Optimal Workup Strategies in Advanced Endometrial Cancer
EP. 3: Factors in Frontline Treatment Decision Making for Endometrial Cancer
EP. 4: Assessing Response to First-Line Therapy in Advanced Endometrial Cancer: Clinical Factors
EP. 5: Chronic Challenges in Endometrial Cancer: Recurrence and Second-Line Therapy
EP. 6: Treatment Choices for Recurrent dMMR Endometrial Cancer
EP. 7: HER2-Positive Endometrial Cancer: A Targeted Approach to Treatment
EP. 8: Treatment for Recurrent Endometrial Cancer: Chemotherapy or Lenvatinib + Pembrolizumab
EP. 9: Endometrial Cancer: Managing Toxicities in Lenvatinib and Pembrolizumab
EP. 10: Revolutionizing Frontline Therapy for Endometrial Cancer: Checkpoint Inhibitors and MMR Status
Now Viewing
EP. 11: Expanding Horizons in Endometrial Cancer Treatment: Beyond Chemotherapy
EP. 12: Diversity and Access to Clinical Trials in Endometrial Cancer